Clinical performance of human papillomavirus based cervical cancer screening algorithm: The result of a large Danish implementation study

被引:0
|
作者
Lindquist, Sofie [1 ]
Kjaer, Susanne K. [1 ,2 ,3 ]
Frederiksen, Kirsten [4 ]
Ornskov, Dorthe [5 ]
Petersen, Lone Kjeld [6 ,7 ]
Munk, Christian [1 ]
Waldstrom, Marianne [8 ,9 ]
机构
[1] Danish Canc Inst, Unit Virus Lifestyle & Genes, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Dept Gynecol, Rigshosp, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[4] Danish Canc Inst, Unit Stat Biostat & Registry, Copenhagen, Denmark
[5] Odense Univ Hosp, Dept Pathol, Odense, Denmark
[6] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark
[7] Univ Southern Denmark, Dept Clin Med, Odense, Denmark
[8] Aarhus Univ Hosp, Dept Pathol, Aarhus, Denmark
[9] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
关键词
cervical cancer; cervical intraepithelial neoplasia; HPV testing; human papillomavirus; screening; BIOPSIES;
D O I
10.1111/aogs.14915
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
IntroductionIn Denmark, where human papillomavirus (HPV) -based cervical cancer screening is being implemented, the aim of this pilot implementation study was to test a specific screening algorithm, assess follow-up examination attendance, and measure the proportion of precancer lesions found in relation to the number of women referred for colposcopy.Material and MethodsFrom May 2017 to December 2020, 36 417 women in the uptake area of the Department of Pathology, Vejle Hospital, Region of Southern Denmark, were included in the HPV group. Women positive for HPV16/18 irrespective of cytology and women positive for other high-risk HPV (hrHPV) types having concomitant abnormal cytology were referred directly to colposcopy. Women positive for other hrHPV types and normal cytology were referred to repeat screening after 12 months, and hrHPV negative to routine screening after three years. We obtained information on screening results and subsequent histological diagnosis from the Danish Pathology Databank through September 2022.Results3.6% of the women were referred to colposcopy after primary screening, 5% to repeat screening after 12 months, and 91.4% back to routine screening. High follow-up rates were observed: 96% attended colposcopy after primary screening, with 91% attending colposcopy after repeat screening. CIN3+ was detected at colposcopy following the primary screening in 28.1% of HPV16/18-positive women and 18.2% of those positive for other hrHPV types with concomitant abnormal cytology. Of the women with other hrHPV and simultaneous ASCUS/LSIL, 8% had CIN3+. At the repeat screening, 43% had become hrHPV negative, 55% were persistently positive for other hrHPV, and 2% had turned positive for HPV16/18. At the colposcopy following repeat screening, 10.1% of the women positive for other hrHPV were diagnosed with CIN3+, in comparison with 11.1% of the HPV16/18-positive women.ConclusionsIn this pilot implementation study, an algorithm for HPV-based screening was evaluated in a Danish setting. The results demonstrated high attendance at follow-up examinations and provided insights into the number of colposcopy referrals and the detection of CIN2 and CIN3+ cases. The results suggest that women testing positive for other hrHPV in combination with ASCUS/LSIL at primary screening could potentially be referred to repeat screening instead of an immediate colposcopy. This Danish pilot study assessed an HPV-based screening algorithm, revealing a high follow-up attendance. Positive hrHPV with ASCUS/LSIL may motivate repeat screening after 12 months, potentially reducing immediate colposcopy referrals while maintaining effective detection of CIN2 and CIN3+ cases.image
引用
收藏
页码:1781 / 1788
页数:8
相关论文
共 50 条
  • [41] Human Papillomavirus Screening: Study of HPV prevalence and cervical cancer in North Indian Women Population
    Misra, Malvika
    Chandravati
    Tripathi, Pratima
    ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH, 2021, 11 (06) : 1561 - 1565
  • [42] Human papillomavirus testing versus cytology in primary cervical cancer screening: End-of-study and extended follow-up results from the Canadian cervical cancer screening trial
    Isidean, Sandra D.
    Mayrand, Marie-Helene
    Ramanakumar, Agnihotram V.
    Gilbert, Laura
    Reid, Stephanie L.
    Rodrigues, Isabel
    Ferenczy, Alex
    Ratnam, Sam
    Coutlee, Francois
    Franco, Eduardo L.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (11) : 2456 - 2466
  • [43] Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan
    Tshomo, Ugyen
    Franceschi, Silvia
    Tshokey, Tshokey
    Tobgay, Tashi
    Baussano, Iacopo
    Tenet, Vanessa
    Heideman, Danielle A. M.
    Snijders, Peter J. F.
    Clifford, Gary M.
    ONCOTARGET, 2017, 8 (42) : 72438 - 72446
  • [44] Should human papillomavirus DNA testing be offered in combination with cytology or as a sole primary screening test in cervical cancer prevention?
    Tristram, Amanda
    FUTURE ONCOLOGY, 2012, 8 (07) : 783 - 786
  • [45] Attitude to Human Papillomavirus Deoxyribonucleic Acid-Based Cervical Cancer Screening in Antenatal Care in Nigeria: A Qualitative Study
    Filade, Temitope E.
    Dareng, Eileen O.
    Olawande, Toyosi
    Fagbohun, Tolani A.
    Adebayo, Amos O.
    Adebamowo, Clement A.
    FRONTIERS IN PUBLIC HEALTH, 2017, 5
  • [46] Comparison of human papillomavirus testing and cytology for cervical cancer screening in a primary health care setting in the Democratic Republic of the Congo
    Mahmud, Salaheddin M.
    Sangwa-Lugoma, Ghislain
    Nasr, Samih H.
    Kayembe, Patrick K.
    Tozin, Rahma R.
    Drouin, Pierre
    Lorincz, Attila
    Ferenczy, Alex
    Franco, Eduardo L.
    GYNECOLOGIC ONCOLOGY, 2012, 124 (02) : 286 - 291
  • [47] Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program
    Gunes, Ali Can
    Ozgul, Nejat
    Turkyilmaz, Murat
    Kara, Fatih
    Unlu, Fahriye
    Ayhan, Ali
    Gultekin, Murat
    CANCER MEDICINE, 2023, 12 (24): : 21751 - 21760
  • [48] Assessing the time dependence of prognostic values of cytology and human papillomavirus testing in cervical cancer screening
    Isidean, Sandra D.
    Wang, Yishu
    Mayrand, Marie-Helene
    Ratnam, Sam
    Coutlee, Francois
    Franco, Eduardo L.
    Abrahamowicz, Michal
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (10) : 2408 - 2418
  • [49] Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
    van Rosmalen, J.
    de Kok, I. M. C. M.
    van Ballegooijen, M.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (06) : 699 - 709
  • [50] Reflex cytology for triage of high-risk human papillomavirus positive self-sampled material in cervical cancer screening: a prospective cohort study
    Loopik, D. L.
    Melchers, W. J. G.
    Vedder, J. E. M.
    van den Brule, A. J. C.
    Massuger, L. F. A. G.
    Bekkers, R. L. M.
    Siebers, A. G.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 127 (13) : 1656 - 1663